Judy Hsu

Partner
Sydney

Biography

Judy is a partner in our Corporate Advisory group.

As a trusted advisor to some of Australia's top private equity and venture capital fund managers, Judy is an increasingly sought after leader in the industry. She has both offshore and cross-border legal and commercial experience, having previously worked in Switzerland, the U.S., and the Channel Islands for a leading global private equity firm.

Judy's expertise lies in corporate and commercial law, with a focus on fund structuring and establishment, mergers and acquisitions, and venture capital.

Experience

Judy’s experience includes advising:

  • Five V Capital in relation to the establishment of Five V Fund V ($770 million), Five V Fund IV ($550 million), Five V Fund III ($250 million), Five V Fund II ($100 million), Five V ESVC Fund II, Five V ESVC Fund I, the open-ended Horizons Fund ($100 million) and several separate account mandates with regulated superannuation funds.

  • Pemba Capital Partners on the establishment of Pemba Fund III (hard cap reached), Pemba Fund II ($380 million+) and a $650 million management led secondaries fund.

  • Quadrant Private Equity with respect to its 7th buyout fund of $1.24 billion and 2nd growth fund of $530 million. 

  • Taronga Ventures on the simultaneous restructuring and capital raising for its Real Tech Ventures fund (negotiating across investors including APG, Ivanhoe Cambridge and Qantas Super).

  • OIF Ventures on the establishment of its Fund II ($100 million+) and Fund III ($140 million) and Opportunity Fund ($100 million).

  • Nash Capital on the establishment of its inaugural PE Fund ($100 million).

  • Square Peg Capital with respect to its 2020 Fund ($600 million), 2018 Fund ($350 million) and 2015 Fund ($200 million), and the sale of its major shareholding in Vend Limited (deal value of US$350 million).

  • Blackbird Ventures with respect to its $100 million partial secondary sale of portfolio companies to Stepstone and HESTA, and the establishment of its 2020 Core Fund and Follow-on Fund.

  • AirTree Ventures on the establishment of its 2019 Fund ($275 million) and 2016 Fund ($250 million).

  • Four of the five shortlisted candidates for the Commonwealth’s $500 million Biomedical Translation Fund program, including acting for the three that were successfully licensed: Brandon Capital, OneVentures and BioScience Managers.

  • SecondQuarter Ventures on the establishment of its Fund II.

Related insights

Insights featuring Judy